uploads///brain _

Microbot Medical Soars on Encouraging Study Data


Jan. 15 2019, Published 12:39 p.m. ET

Stock price soars

Today, Microbot Medical (MBOT) announced a registered direct offering worth $3 million at $6.50 per share, and yesterday, the company announced results demonstrating the operational effectiveness of its self-cleaning shunt. These results confirmed those of pre-clinical studies of the product’s applicability in treating hydrocephalus.

This news has boosted Microbot stock by ~70% from yesterday’s closing price of $9.79, which was 307.91% higher than its previous closing price. Microbot has a market capitalization of $51.84 million, making it a microcap stock. Companies with a market capitalization under $300 million are generally exposed to higher-than-average risks.

Article continues below advertisement

Stock returns

As of yesterday, Microbot stock had returned 417.99% in the last week, 387.06% in the last month, 67.35% in the last quarter, -10.27% in the last half year, -39% in the last year, and 469.19% year-to-date.

Recommendations for Microbot Medical

The only analyst covering Microbot has recommended “hold,” and that analyst’s target price of $26.25 for the stock is 52.53% higher than its current price of $17.21.


More From Market Realist

  • CONNECT with Market Realist
  • Link to Facebook
  • Link to Twitter
  • Link to Instagram
  • Link to Email Subscribe
Market Realist Logo
Do Not Sell My Personal Information

© Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.